Difamilast Approved as Topical PDE4 Inhibitor for Atopic Dermatitis
Difamilast joins crisaborole (Eucrisa) as the second topical PDE4 inhibitor cleared for U.S. atopic dermatitis, per Pharmacy Times. Label details, trial endpoints and pricing were not in the source h…